Author: Marc Lichtenfeld, Wealthy Retirement

Moreover, the company has increased its dividend every quarter for the past 82 quarters. And considering that its funds from operations (FFO) is rising and easily covering the dividend, it should have no problem keeping that streak of quarterly dividend hikes alive for the foreseeable future.

The company has a stellar track record of annual dividend hikes and it can still easily cover the dividend.

A dividend raise for the 35th straight year is a safe bet.

There will always be demand for their products and services.

You can hit some big home runs by investing in the biotech sector… if you handle your risk properly.